ARTICLE | Distillery Therapeutics
Therapeutics: P. falciparum phenylalanyl-tRNA synthetase
October 6, 2016 7:00 AM UTC
In vitro and mouse studies identified a bicyclic azetidine-based inhibitor of Plasmodium falciparum phenylalanine-tRNA synthetase that could help treat malaria. Screening of a small molecule library i...